对固体瘤的分子细胞遗传学分析进行比较基因组杂交
A Kallioniemi1, O P Kallioniemi, D Sudar
1Department of Laboratory Medicine, University of California, San Francisco 94143.
Science (New York, N.Y.)
|October 30, 1992
概括
相对基因组杂交映射DNA复制数在整个基因组中的变化. 这项技术在膀瘤中发现了16个新的放大区域,推动了癌症研究.
科学领域:
- 基因组学就是基因组学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 相对基因组杂交 (CGH) 是一种用于检测染色体复制数变化的技术.
- 了解DNA序列拷贝数变异对于识别与癌症等疾病相关的遗传变化至关重要.
研究的目的:
- 为了创建一个全基因组的DNA序列复制号码的地图.
- 用CGH在膀瘤中识别新的放大位点.
主要方法:
- 同时混合差异标记的测试DNA和正常参考DNA以达到正常染色体扩散.
- 使用两种不同的色素检测杂交.
- 分析染色体沿线的染色体强度比,以确定DNA增加或损失的区域.
主要成果:
- CGH成功地绘制了整个基因组中的DNA序列复制数变异.
- 分析揭示了瘤细胞系和初级膀瘤中的16个明显的放大区域.
- 许多这些放大位置以前是未知的.
结论:
- CGH是全基因组复制数分析的有效方法.
- 该研究确定了膀癌中的新增放大区域,为研究提供了新的目标.
- 这种技术有可能促进对各种遗传疾病的理解.
相关概念视频
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...